|

Trabectedin Clinical Trials

7 actively recruiting trials across 1 location

Also known as: Dacarbazine, Gemcitabine, Trabectedin arm, Yondelis

Other5 trials

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
Phase 2
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Phase 2
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Phase 1/2
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
Phase 2
tTF-NGR Randomized Study - STS
Phase 3

Santa Monica, California2 trials

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

Sant P Chawla

Phase 2
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Sarcoma Oncology Research Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.